Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 2662
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70996
So sorry to hear about Alan C. My sincere
(5)
Fit007
01/03/2022 12:18:40 PM
70995
I appreciated Alan Cs daily report on trading.
(3)
Jimvette
01/03/2022 11:02:19 AM
70994
AlanC regrettably passed away.
(2)
someconcerns
01/03/2022 9:59:49 AM
70993
Does anyone know whereabout AlanC?
Zadie
01/03/2022 7:30:45 AM
70992
Early, but new variant possibly greater than
(1)
djs7
01/02/2022 11:18:15 PM
70991
Let's pray Brilacidin can find its specific path
(1)
djs7
01/02/2022 10:19:43 PM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
Newer
Older
Recent Articles
Key Share Transactions and Managerial Responsibilities Overview
Significant Growth on the Horizon for Cholesterol Control Supplements
Auto Dealer Software Market Predicted to Reach Over $8 Billion
FLSmidth's Largest HPGR Order Marks a Major Milestone
Auction Outcomes for Treasury Bills on November 28, 2024
KryptoGO Implements Cutting-Edge Security for Digital Wallets
Engaging Insights on Sectra's Upcoming Financial Events
Markus Wörmanseder's Recent Transactions with Harvia Plc
Wolters Kluwer Announces Significant Share Buyback Updates
LVMH Announces Generous €5.50 Interim Dividend for Shareholders
Biotangents Innovates Dairy Farming with Diagnostic Device
Exploring Nuclear Technology: CNNC's Commitment to Global Welfare
Unlock Your Beauty: Grab Up to 60% Off COSRX Skincare Deals
Olverembatinib's Inclusion in National Drug List Empowers Patients
Xiaomi Strengthens Global App Ecosystem at Recent Conference
Artificial Turf Market Growth Driven by Sustainability Trends
Photocat A/S Partners with Wimhof GmbH to Launch Garden Solutions
BOW Appoints Raspberry Pi Co-Founder Liz Upton as Chair
Lindab Focuses on Structural Adjustments for Future Growth
cBrain Introduces Innovative Waste Management Solutions in Thailand
Enhancing Online Safety for Seniors with SeniorMatch's New Feature
UNIVELO's Exclusive Deal for AIMA E-Bikes Revolutionizes Canada
OKX Expands Reach with New Launch of Exchange in Belgium
Nokia Empowers Cloudbear with Enhanced Data Center Solutions
Celebrating 5 Years of Partnership Between GXO and OBI
Cincoze Unveils Advanced GPU Embedded Computers for Edge AI
Biwatt Unveils Innovative Sodium-ion Battery Solutions
Deepcoin Launches Innovative K-Line Feature for Traders
DAHON Drives Green Innovation with New D-VELO Technology
Shanghai Celebrates Contributions of 50 Expats with Awards
Discover ASSA ABLOY's Upcoming Capital Markets Day Event
Smartee Celebrates New Paris Office Opening with Gala Event
Belgian Hospital Enhances Patient Care with Sectra Imaging
Raytron Innovates with Infrared Solutions for Safer Driving
Heidelberg Materials Expands Operations with Strategic Acquisition
Pharmaceutical Glass Packaging Market Set for Long-Term Growth
Exploring AI and Crypto Synergy: Future Innovations Ahead
IDEX Biometrics ASA CEO Expands Stake in Subsequent Offering
Interoil Reports October Production Growth and Updates
Innofactor Plc Completes Share Cancellation for Better Capital Structure
Understanding Timely Communication for Serious Online Relationships
Wuxi Economic Development Zone Enhances Business Growth Strategies
Biwatt Unveils Cutting-Edge Sodium-ion Technologies in Düsseldorf
ASSA ABLOY Announces Capital Markets Day for 2025 Event
Rémy Cointreau's Financial Performance: Analysis and Outlook
Shanghai Promotion Conference Highlights Global Service Growth
Major Milestone Achieved as Amaroq Minerals Pours First Gold
ZetaDisplay AB Reports Significant Growth in Q3 2024
Serabi Gold Reports Strong Financial Performance
PayPoint Takes Strategic Step with Share Buyback Initiative